概括
螺旋乳有效地治疗了英格兰和威尔士妇女的. 这项随机对照试验证实了其在治疗这种常见皮肤疾病方面的有效性.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 湿是一种常见的皮肤疾病,影响了许多女性.
- 荷尔蒙疗法通常用于治疗女性的.
- 螺旋龙是一种抗雄激素药物,对有潜在的益处.
研究的目的:
- 评估斯皮罗诺拉克在治疗女性的有效性.
- 进行一个务实的,多中心的,第三阶段的,双盲的,随机对照试验.
主要方法:
- 在英格兰和威尔士招募患有的女性.
- 随机对照试验设计采用双盲方法.
- 多中心参与以确保通用性.
主要成果:
- 螺旋乳在改善一般性方面表现出显著的有效性.
- 该治疗被研究参与者容忍得很好.
- 在现实世界的临床环境中观察到积极的结果.
结论:
- 螺旋乳是一种有效的治疗选择,用于女性.
- 这些发现支持在临床实践中用于管理中使用螺旋.
- 进一步的研究可能会探索长期的疗效和安全性.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
367
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
367
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
303
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
303
Drugs for Treatment of Constipation-Predominant IBS
218
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
218
Drugs for Treatment of Diarrhea-Predominant IBS
216
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
216
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K


